Literature DB >> 16033956

Bevacizumab therapy for POEMS syndrome.

Ashraf Badros, Neil Porter, Ann Zimrin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16033956     DOI： 10.1182/blood-2005-03-0910

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  16 in total

Review 1.  Amyloidosis and POEMS syndrome.

Authors:  Cheng E Chee; Angela Dispenzieri; Morie A Gertz
Journal:  Expert Opin Pharmacother       Date:  2010-06       Impact factor: 3.889

Review 2.  Molecularly targeted therapies for dysimmune neuropathies.

Authors:  Andreas A Argyriou
Journal:  Mol Med       Date:  2009-05-05       Impact factor: 6.354

Review 3.  Development of POEMS syndrome after an initial manifestation of solitary plasmacytoma.

Authors:  Motohiro Shindo; Kazuya Sato; Masayo Yamamoto; Yasumichi Toki; Mayumi Hatayama; Satoshi Ito; Kazuhiko Ichiki; Naoka Okamura; Takaaki Hosoki; Katsuya Ikuta; Junki Inamura; Shinji Watanabe; Yoshihiro Torimoto; Yutaka Kohgo
Journal:  Int J Hematol       Date:  2011-05-07       Impact factor: 2.490

Review 4.  How I treat POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

Review 5.  Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.

Authors:  Satoshi Kuwabara; Angela Dispenzieri; Kimiyoshi Arimura; Sonoko Misawa; Chiaki Nakaseko
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

6.  Intracranial hemangiomas in a patient with POEMS syndrome.

Authors:  G D Maurer; J Schittenhelm; U Ernemann; V A J Kempf; R Ritz; M Weller; F Schmidt
Journal:  J Neurol       Date:  2009-11-27       Impact factor: 4.849

7.  Genetic delivery of bevacizumab to suppress vascular endothelial growth factor-induced high-permeability pulmonary edema.

Authors:  Masaki Watanabe; Julie L Boyer; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2009-06       Impact factor: 5.695

Review 8.  POEMS Syndrome: an Enigma.

Authors:  Rahma Warsame; Uday Yanamandra; Prashant Kapoor
Journal:  Curr Hematol Malig Rep       Date:  2017-04       Impact factor: 4.213

9.  Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes (POEMS) syndrome refractory to complete serum vascular endothelial growth factor (VEGF) blockade: insights from sequential VEGF monitoring.

Authors:  Joëlle Guitard; Adèle Pillet; Martin Soubrier; Anne Modesto; Dominique Chauveau
Journal:  NDT Plus       Date:  2009-07-22

10.  Waldenstrom's Macroglobulinemia and Peripheral Neuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes with a Bleeding Diathesis and Rash.

Authors:  S Haider; T Latif; A Hochhausler; F Lucas; N Abdel Karim
Journal:  Case Rep Oncol Med       Date:  2013-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.